Hypoglycaemia increases aldosterone in a dose-dependent fashion

Diabetic Medicine

Volumn 27, Issue 11, 2010, Pages 1250-1255

  Adler, G K ^a   Bonyhay, I ^b   Curren, V ^a   Waring, E ^b   Freeman, R ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Aldosterone; Autonomic hypoglycaemia; Nervous system

Indexed keywords

ALDOSTERONE; CORTICOTROPIN; GLUCOSE; MINERALOCORTICOID RECEPTOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INFLAMMATION; MALE; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; ALDOSTERONE; BLOOD GLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; RENIN-ANGIOTENSIN SYSTEM;

EID: 77958612676     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03087.x     Document Type: Article

References (30)

1. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB et al. Effects of intensive glucose lowering in type-2 diabetes. N Engl J Med 2008; 358: 2545-2559.
2. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297.
3. Brown NJ. Aldosterone and vascular inflammation. Hypertension 2008; 51: 161-167.
4. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709-717.
5. Guder G, Bauersachs J, Frantz S, Weismann D, Allolio B, Ertl G et al. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation 2007; 115: 1754-1761.
6. Beygui F, Collet JP, Benoliel JJ, Vignolles N, Dumaine R, Barthelemy O et al. High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction. Circulation 2006; 114: 2604-2610.
7. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309-1321.
8. Perlstein TS, Gerhard-Herman M, Hollenberg NK, Williams GH, Thomas A. Insulin induces renal vasodilation, increases plasma renin activity, and sensitizes the renal vasculature to angiotensin receptor blockade in healthy subjects. J Am Soc Nephrol 2007; 18: 944-951.
9. Rooney DP, Edgar JD, Sheridan B, Atkinson AB, Bell PM. The effects of low dose insulin infusions on the renin angiotensin and sympathetic nervous systems in normal man. Eur J Clin Invest 1991; 21: 430-435.
10. Ramirez G, Ganguly A, Brueggemeyer CD. Acute effect of captopril on aldosterone secretory responses to endogenous or exogenous adrenocorticotropin. J Clin Endocrinol Metab 1988; 66: 46-50.
11. Worck RH, Ibsen H, Frandsen E, Dige-Petersen H. AT1 receptor blockade and the sympathoadrenal response to insulin-induced hypoglycemia in humans. Am J Physiol 1997; 272: E415-E421.
12. Trovati M, Massucco P, Mularoni E, Cavalot F, Anfossi G, Mattiello L et al. Insulin-induced hypoglycaemia increases plasma concentrations of angiotensin II and does not modify atrial natriuretic polypeptide secretion in man. Diabetologia 1988; 31: 816-820.
13. Frier BM, Al Dujaili EA, Corrall RJ, Pritchard JL, Edwards CR. Autonomic neural control mechanisms and the release of adrenal steroids after hypoglycaemia in man. Horm Metab Res 1984; 16: S138-141.
14. Trovati M, Massucco P, Anfossi G, Cavalot F, Mularoni E, Mattiello L et al. Insulin influences the renin-angiotensin-aldosterone system in humans. Metabolism 1989; 38: 501-503.
15. Hata S, Kunita H, Okamoto M. Aldosterone response to hypoglycemia: evidence of ACTH mediation. J Clin Endocrinol Metab 1976; 43: 173-177.
16. Adler GK, Bonyhay I, Failing H, Waring E, Dotson S, Freeman R. Antecedent hypoglycemia impairs autonomic cardiovascular function - implications for rigorous glycemic control. Diabetes 2009; 58: 360-366.
17. Adler GK, Kinsley BT, Hurwitz S, Mossey CJ, Goldenberg DL. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 1999; 106: 534-543.
18. Scherrer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997; 96: 4104-4113.
19. DiBona GF. Neural control of the kidney: past, present, and future. Hypertension 2003; 41: 621-624.
20. Fletcher J, Buch AN, Routledge HC, Chowdhary S, Coote JH, Townend JN. Acute aldosterone antagonism improves cardiac vagal control in humans. J Am Coll Cardiol 2004; 43: 1270-1275.
21. Yee KM, Struthers AD. Endogenous angiotensin II and baroreceptor dysfunction: a comparative study of losartan and enalapril in man. Br J Clin Pharmacol 1998; 46: 583-588.
22. Schmidt BM, Horisberger K, Feuring M, Schultz A, Wehling M. Aldosterone blunts human baroreflex sensitivity by a nongenomic mechanism. Exp Clin Endocrinol Diabetes 2005; 113: 252-256.
23. Monahan KD, Leuenberger UA, Ray CA. Aldosterone impairs baroreflex sensitivity in healthy adults. Am J Physiol Heart Circ Physiol 2007; 292: H190-H197.
24. De Ferrari GM, Sanzo A, Bertoletti A, Specchia G, Vanoli E, Schwartz PJ. Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol 2007; 50: 2285-2290.
25. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators [see comments]. Lancet 1998; 351: 478-484.
26. Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR et al. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation 2008; 117: 2253-2261.
27. Luther JM, Gainer JV, Murphey LJ, Yu C, Vaughan DE, Morrow JD et al. Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism. Hypertension 2006; 48: 1050-1057.
28. Dotson S, Freeman R, Failing HJ, Adler GK. Hypoglycemia increases serum interleukin-6 levels in healthy men and women. Diabetes Care 2008; 31: 1222-1223.
29. Razavi NL, Kitabchi AE, Stentz FB, Wan JY, Larijani BA, Tehrani MM et al. Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism 2009; 58: 443-448.
30. Gomez AM, Rueda A, Sainte-Marie Y, Pereira L, Zissimopoulos S, Zhu X et al. Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins. Circulation 2009; 119: 2179-2187.